Publication:
Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.

dc.contributor.authorde la Coba Ortiz, Cristóbal
dc.contributor.authorArgüelles Arias, Federico
dc.contributor.authorMartín de Argila de Prados, Carlos
dc.contributor.authorJúdez Gutiérrez, Javier
dc.contributor.authorLinares Rodríguez, Antonio
dc.contributor.authorOrtega Alonso, Aida
dc.contributor.authorRodríguez de Santiago, Enrique
dc.contributor.authorRodríguez-Téllez, Manuel
dc.contributor.authorVera Mendoza, María Isabel
dc.contributor.authorAguilera Castro, Lara
dc.contributor.authorÁlvarez Sánchez, Ángel
dc.contributor.authorAndrade Bellido, Raúl Jesús
dc.contributor.authorBao Pérez, Fidencio
dc.contributor.authorCastro Fernández, Manuel
dc.contributor.authorGiganto Tomé, Froilán
dc.date.accessioned2023-01-25T08:31:36Z
dc.date.available2023-01-25T08:31:36Z
dc.date.issued2016
dc.description.abstractIn the last few years a significant number of papers have related the use of proton-pump inhibitors (PPIs) to potential serious adverse effects that have resulted in social unrest. The goal of this paper was to provide a literature review for the development of an institutional position statement by Sociedad Española de Patología Digestiva (SEPD) regarding the safety of long-term PPI use. A comprehensive review of the literature was performed to draw conclusions based on a critical assessment of the following: a) current PPI indications; b) vitamin B12 deficiency and neurological disorders; c) magnesium deficiency; d) bone fractures; e) enteric infection and pneumonia; f) interactions with thienopyridine derivatives; e) complications in cirrhotic patients. Current PPI indications have remained unchanged for years now, and are well established. A general screening of vitamin B12 levels is not recommended for all patients on a PPI; however, it does seem necessary that magnesium levels be measured at therapy onset, and then monitored in subjects on other drugs that may induce hypomagnesemia. A higher risk for bone fractures is present, even though causality cannot be concluded for this association. The association between PPIs and infection with Clostridium difficile is mild to moderate, and the risk for pneumonia is low. In patients with cardiovascular risk receiving thienopyridines derivatives it is prudent to adequately consider gastrointestinal and cardiovascular risks, given the absence of definitive evidence regardin potential drug-drug interactions; if gastrointestinal risk is found to be moderate or high, effective prevention should be in place with a PPI. PPIs should be cautiously indicated in patients with decompensated cirrhosis. PPIs are safe drugs whose benefits outweigh their potential side effects both short-term and long-term, provided their indication, dosage, and duration are appropriate.
dc.identifier.doi10.17235/reed.2016.4232/2016
dc.identifier.issn1130-0108
dc.identifier.pmid27034082
dc.identifier.unpaywallURLhttps://doi.org/10.17235/reed.2016.4232/2016
dc.identifier.urihttp://hdl.handle.net/10668/9966
dc.issue.number4
dc.journal.titleRevista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
dc.journal.titleabbreviationRev Esp Enferm Dig
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Virgen Macarena
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.page.number207-24
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rights.accessRightsopen access
dc.subject.meshDrug Interactions
dc.subject.meshEvidence-Based Medicine
dc.subject.meshFractures, Bone
dc.subject.meshHumans
dc.subject.meshInfections
dc.subject.meshLiver Cirrhosis
dc.subject.meshMagnesium Deficiency
dc.subject.meshNervous System Diseases
dc.subject.meshProton Pump Inhibitors
dc.titleProton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number108
dspace.entity.typePublication

Files